标题：麦默通微创旋切手术治疗乳腺肿物的临床应用

      作者：李贤勇 1，黄胜超 1，陈小东 1，丁洪飞 1，徐晓红 2，戴海霞 2，张远起 1，张 智 1，李建文 1?
    (广东医学院附属医院血管甲状腺乳腺外科 1、超声科 2，广东 湛江 524001)

      卷次： 2015年26卷19期

      【摘要】 目的 探讨麦默通微创旋切手术治疗乳腺肿物的临床应用价值及经验。方法 回顾性分析2009
年10月至2013年10月广东医学院附属医院乳腺外科2 496例行乳腺肿物微创旋切术的乳腺肿物患者的临床资
料。结果 微创手术切口平均长度为(0.4±0.1) cm、手术平均时间为(15±5) min、手术平均出血量为(7.6±3.3) ml。
微创手术后有 42例出现血肿，35例出现皮下瘀斑，无切口感染开裂，8例出现乳腺塌陷变形，15例发生瘢痕形
成。术后平均恢复时间为(4.5±1.2) d。肿块切除后常规病理结果显示，良性病变占比绝大部分，占比为98.84%，
其中尤以纤维腺瘤居多，占53.82%。共发现恶性病变60例，其中导管原位癌28例，小叶原位癌与浸润性导管癌各
16例。结论 麦默通微创旋切手术安全系数高，创伤小，手术时间短，术中出血量少，且能准确切除肿块，术后疤痕
较小，不影响乳房的美观，预后佳，目前已成为乳腺微创外科不可或缺的重要工具，但其应用仍有一定的局限性。

      【关键词】 麦默通微创旋切手术；乳腺肿物；临床应用

      【中图分类号】 R588 【文献标识码】 A 【文章编号】 1003—6350（2015）19—2854—03


Clinical application of Mammotome biopsy system for the resection of breast tumors.
LI Xian-yong 1, HUANG
Sheng-chao 1, CHEN Xiao-dong 1, DING Hong-fei 1, XU Xiao-hong 2, DAI Hai-xia 2, ZHANG Yuan-qi 1, ZHANG Zhi 1,
LI Jian-wen 1. Department of Vascular, Thyroid and Breast Surgery 1, Department of Ultrasound 2, the Affiliated Hospital
of Guangdong Medical College, Zhanjiang 524001, Guangdong, CHINA

【Abstract】 Objective To explore the clinical value and experience of minimally invasive Mammotome biopsy
system in the diagnosis and treatment of breast tumor. Methods The clinical data of 2 496 patients with breast disease
underwent Mammotome biopsy from October 2009 to October 2014 were retrospectively reviewed. Results The aver-
age length of the incision was (0.4±0.1) cm, and the mean operative time was (15±5) min, with mean blood
loss of (7.6±3.3) ml. After surgery, there were 42 cases of hematoma, 35 cases of subcutaneous bruising, no case of
cracking wound infection, 8 cases of breast collapse deformation, 15 cases of scarring. The mean recovery time was
(4.5±1.2) days. The pathological results after operation showed that most tumors were benign lesions (accounting for
98.84%), especially the fibroadenoma (accounting for 53.82%). There were 60 cases of malignant lesions, including
28 cases of ductal carcinoma in situ, 16 cases of lobular carcinoma in situ and 16 cases of invasive ductal carcinoma.
Conclusion Minimally invasive Mammotome biopsy has the advantages of good safety, shorter operating time, less
blood loss, which can removal the tumor accurately, with smaller postoperative scar and better prognosis. It has become
an indispensable tool for minimally invasive surgery in breast tumors, but its application still has some limitations.

      【Key words】 Minimally invasive Mammotome biopsy; Breast tumor; Clinical application
·论 著·doi:10.3969/j.issn.1003-6350.2015.19.1039